{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:15:15Z","timestamp":1780334115532,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["HE 7607\/1-2"],"award-info":[{"award-number":["HE 7607\/1-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["HA 7783\/1-2"],"award-info":[{"award-number":["HA 7783\/1-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["KA 1942\/2-1"],"award-info":[{"award-number":["KA 1942\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["HA 7783\/4-1"],"award-info":[{"award-number":["HA 7783\/4-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ejmech.2024.117045","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T18:29:16Z","timestamp":1731090556000},"page":"117045","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Multicomponent syntheses enable the discovery of novel quisinostat-derived chemotypes as histone deacetylase inhibitors"],"prefix":"10.1016","volume":"281","author":[{"given":"Daniel","family":"Stopper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Buntrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lais Pessanha","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Sch\u00e4ker-H\u00fcbner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Held","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias U.","family":"Kassack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9765-5975","authenticated-orcid":false,"given":"Finn K.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.117045_bib1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrg.2016.59","article-title":"The molecular hallmarks of epigenetic control","volume":"17","author":"Allis","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ejmech.2024.117045_bib2","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1002\/anie.200461346","article-title":"Epigenetics--an epicenter of gene regulation: histones and histone-modifying enzymes","volume":"44","author":"Biel","year":"2005","journal-title":"Angew. Chem., Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2024.117045_bib3","doi-asserted-by":"crossref","first-page":"12460","DOI":"10.1021\/acs.jmedchem.0c00830","article-title":"Thirty years of HDAC inhibitors: 2020 insight and hindsight","volume":"63","author":"Ho","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117045_bib4","article-title":"FDA approves an HDAC inhibitor for Duchenne muscular dystrophy","author":"Mullard","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2024.117045_bib5","doi-asserted-by":"crossref","first-page":"13143","DOI":"10.1073\/pnas.93.23.13143","article-title":"Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase","volume":"93","author":"Darkin-Rattray","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2024.117045_bib6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2174\/156802609788085313","article-title":"Targeting histone deacetylase inhibitors for anti-malarial therapy","volume":"9","author":"Andrews","year":"2009","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117045_bib7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/icb.2011.97","article-title":"HDAC inhibitors in parasitic diseases","volume":"90","author":"Andrews","year":"2012","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.ejmech.2024.117045_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijpddr.2015.05.004","article-title":"Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites","volume":"5","author":"Engel","year":"2015","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ejmech.2024.117045_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116782","article-title":"Development of peptoid-based heteroaryl-decorated histone deacetylase (HDAC) inhibitors with dual-stage antiplasmodial activity","author":"Stopper","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117045_bib10","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1111\/febs.14376","article-title":"Genome-wide survey and phylogenetic analysis of histone acetyltransferases and histone deacetylases of Plasmodium falciparum","volume":"285","author":"Kanyal","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2024.117045_bib11","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0960-894X(97)00284-9","article-title":"Analogues of trichos\u0442atin a and trapoxin B as histone deacetylase inhibitors","volume":"7","author":"Jung","year":"1997","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2024.117045_bib12","doi-asserted-by":"crossref","first-page":"6841","DOI":"10.1158\/1078-0432.CCR-09-0547","article-title":"JNJ-26481585, a novel \"second-generation\" oral histone deacetylase inhibitor, shows broad-spectrum preclinical antitumoral activity","volume":"15","author":"Arts","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2024.117045_bib13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/pbc.24724","article-title":"Initial testing (stage 1) of the histone deacetylase inhibitor, quisinostat (JNJ-26481585), by the Pediatric Preclinical Testing Program","volume":"61","author":"Carol","year":"2014","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.ejmech.2024.117045_bib14","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.3109\/10428194.2015.1117611","article-title":"Quisinostat, bortezomib, and dexamethasone combination therapy for relapsed multiple myeloma","volume":"57","author":"Moreau","year":"2016","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.ejmech.2024.117045_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41421-020-00215-4","article-title":"A novel multistage antiplasmodial inhibitor targeting Plasmodium falciparum histone deacetylase 1","volume":"6","author":"Huang","year":"2020","journal-title":"Cell Discov"},{"key":"10.1016\/j.ejmech.2024.117045_bib16","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1021\/acs.jmedchem.0c02104","article-title":"Discovery of novel Plasmodium falciparum HDAC1 inhibitors with dual-stage antimalarial potency and improved safety based on the clinical anticancer drug candidate quisinostat","volume":"64","author":"Li","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117045_bib17","doi-asserted-by":"crossref","DOI":"10.15212\/AMM-2022-0007","article-title":"Design and synthesis of novel hydroxamic acid derivatives based on quisinostat as promising antimalarial agents with improved safety","volume":"1","author":"Wang","year":"2022","journal-title":"Acta Materia Medica"},{"key":"10.1016\/j.ejmech.2024.117045_bib18","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1021\/acsmedchemlett.3c00012","article-title":"Accelerating drug discovery: synthesis of complex chemotypes via multicomponent reactions","volume":"14","author":"Buskes","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.117045_bib19","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1021\/acs.chemrev.1c00631","article-title":"Green chemistry in the synthesis of pharmaceuticals","volume":"122","author":"Kar","year":"2022","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2024.117045_bib20","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1039\/C5CC10301K","article-title":"Rational design and diversity-oriented synthesis of peptoid-based selective HDAC6 inhibitors","volume":"52","author":"Diedrich","year":"2016","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2024.117045_bib21","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1021\/acs.jmedchem.7b00197","article-title":"Design, multicomponent synthesis, and anticancer activity of a focused histone deacetylase (HDAC) inhibitor library with peptoid-based cap groups","volume":"60","author":"Krieger","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117045_bib22","doi-asserted-by":"crossref","first-page":"11260","DOI":"10.1021\/acs.jmedchem.9b01489","article-title":"Synthesis of peptoid-based class I-selective histone deacetylase inhibitors with chemosensitizing properties","volume":"62","author":"Krieger","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117045_bib23","doi-asserted-by":"crossref","first-page":"10339","DOI":"10.1021\/acs.jmedchem.9b01888","article-title":"Multicomponent synthesis, binding mode, and structure-activity relationship of selective histone deacetylase 6 (HDAC6) inhibitors with bifurcated capping groups","volume":"63","author":"Re\u00dfing","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117045_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201600347","article-title":"Design and synthesis of novel anti-plasmodial histone deacetylase inhibitors containing an alkoxyamide connecting unit","volume":"350","author":"Alves Avelar","year":"2017","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2024.117045_bib25","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1016\/j.bmc.2016.06.040","article-title":"Kinetic and structural insights into the binding of histone deacetylase 1 and 2 (HDAC1, 2) inhibitors","volume":"24","author":"Wagner","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117045_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11262","article-title":"Insights into the activation mechanism of class I HDAC complexes by inositol phosphates","volume":"7","author":"Watson","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2024.117045_bib27","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/emboj\/cdg115","article-title":"HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo","volume":"22","author":"Zhang","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2024.117045_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abi6696","article-title":"Class I histone deacetylases (HDAC1-3) are histone lysine delactylases","volume":"8","author":"Moreno-Yruela","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2024.117045_bib29","doi-asserted-by":"crossref","first-page":"17796","DOI":"10.1021\/acs.jmedchem.4c01817","article-title":"Hydrazide-based class I selective HDAC inhibitors completely reverse chemoresistance synergistically in platinum-resistant solid cancer cells","volume":"67","author":"Kraft","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117045_bib30","series-title":"Molecular Operating Environment (MOE)","year":"2022"},{"key":"10.1016\/j.ejmech.2024.117045_bib31","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejmech.2024.117045_bib32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2","article-title":"The penultimate rotamer library","volume":"40","author":"Lovell","year":"2000","journal-title":"Proteins"},{"key":"10.1016\/j.ejmech.2024.117045_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00085-19","article-title":"Ivermectin impairs the development of sexual and asexual stages of Plasmodium falciparum in vitro","volume":"63","author":"de Carvalho","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.117045_bib34","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2024.117045_bib35","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1128\/AAC.49.8.3575-3577.2005","article-title":"Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing","volume":"49","author":"Noedl","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.117045_bib36","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1021\/acs.orglett.8b01118","article-title":"Multicomponent synthesis and binding mode of Imidazo1,2- apyridine-capped selective HDAC6 inhibitors","volume":"20","author":"Mackwitz","year":"2018","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2024.117045_bib37","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0003-2697(03)00276-8","article-title":"Nonisotopic substrate for assaying both human zinc and NAD+-dependent histone deacetylases","volume":"319","author":"Heltweg","year":"2003","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejmech.2024.117045_bib38","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ejmech.2014.05.050","article-title":"Discovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stages","volume":"82","author":"Hansen","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117045_bib39","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1021\/jm300526r","article-title":"Substrates for efficient fluorometric screening employing the NAD-dependent sirtuin 5 lysine deacylase (KDAC) enzyme","volume":"55","author":"Madsen","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117045_bib40","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1021\/jm301254q","article-title":"Histone deacetylase (HDAC) inhibitors with a novel connecting unit linker region reveal a selectivity profile for HDAC4 and HDAC5 with improved activity against chemoresistant cancer cells","volume":"56","author":"Marek","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117045_bib41","doi-asserted-by":"crossref","first-page":"353","DOI":"10.7150\/jca.13754","article-title":"Ellagic acid and resveratrol prevent the development of cisplatin resistance in the epithelial ovarian cancer cell line A2780","volume":"7","author":"Engelke","year":"2016","journal-title":"J. Cancer"},{"key":"10.1016\/j.ejmech.2024.117045_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20123052","article-title":"Class I-histone deacetylase (HDAC) inhibition is superior to pan-HDAC inhibition in modulating cisplatin potency in high grade serous ovarian cancer cell lines","volume":"20","author":"Bandolik","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.117045_bib43","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v012.i05","article-title":"Bioassay analysis using R","volume":"12","author":"Ritz","year":"2005","journal-title":"J. Stat. Software"},{"key":"10.1016\/j.ejmech.2024.117045_bib44","series-title":"R: A Language and Environment for Statistical Computing","year":"2013"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424009279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424009279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:07:26Z","timestamp":1777529246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424009279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":44,"alternative-id":["S0223523424009279"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117045","relation":{"has-preprint":[{"id-type":"doi","id":"10.26434\/chemrxiv-2024-0bp39-v2","asserted-by":"object"},{"id-type":"doi","id":"10.26434\/chemrxiv-2024-0bp39","asserted-by":"object"}]},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multicomponent syntheses enable the discovery of novel quisinostat-derived chemotypes as histone deacetylase inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117045"}}